Last reviewed · How we verify
Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
Our study was a single-blind, randomised, controlled, multicentre study. The study was planned to include 140 patients admitted to the general ward for subcutaneous insulin therapy, who were randomly divided into two groups in the ratio of 1:1, one group with an artificial intelligence assisted insulin dosimetry system to adjust the insulin dose to control their blood glucose, and the other group with a physician instituted insulin dosimetry adjustments to control their blood glucose. The effectiveness and safety of the system was confirmed by comparing the glycaemic control and risk of adverse events between the two groups.
Details
| Lead sponsor | Shanghai Zhongshan Hospital |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 140 |
| Start date | Fri Apr 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed May 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Diabetes Type 2
Interventions
- AI-assisted insulin dose adjustment model
- doctor's insulin dose adjustment
Countries
China